Self-assembling polymeric nanocarriers to target inflammatory lesions in ulcerative colitis
2017
Abstract We have developed a self-assembling polymeric
nanocarrierto deliver the potent
immunosuppressive drugCyclosporine A (CsA) to inflammatory lesions in ulcerative
colitis(UC) patients. Our
nanocarrierhas a high drug loading capacity and efficiently targets its CsA payload to the diseased tissue after local administration. Tissue drug levels were several orders of magnitude higher in animals suffering from a
trinitrobenzene-sulfonic acid (TNBS) – induced
colitis, compared to healthy control animals; no drug was detectable in the plasma, underlining the localized delivery strategy. An efficient reduction in inflammation score was obtained with a CsA dose of 1 mg/mL. Therapeutic efficacy was comparable to 5-
aminosalicylic acid(5-ASA), the positive control treatment in the TNBS - induced
colitismodel. Repetitive treatment of healthy animals with CsA
nanocarriersfor seven days was well tolerated with no alterations in colon histology.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
36
References
17
Citations
NaN
KQI